Innovating Works

HPA

RISK - IR: Risk Stem Cells and Tissue Kinetics Ionising Radiation HEALTH PROTECTION AGENCY HPA participó en un FP7: The magnitude of cancer risk in humans exposed to low radiation doses (<100mSv) is uncertain and depends upon extrapolation of human populat...
Financiado
SLAM: Standardisation of laboratory analytical methods HEALTH PROTECTION AGENCY HPA participó en un FP7: SLAM is a project proposal for a supporting and coordinating activity with the objective of reviewing the needs for standardisation of CBRN...
Financiado
EVA: European Virus Archive HEALTH PROTECTION AGENCY HPA participó en un FP7: During the past 70 years or more, thousands of viruses have been isolated and partly characterised by experts working in different countries...
Financiado
OPTIMALVAC: Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation HEALTH PROTECTION AGENCY HPA participó en un FP7: A broad-range of candidate malaria vaccines derived from diverse novel technologies have resulted from the multiple approaches being taken b...
Financiado
SOLO: Epidemiological Studies of Exposed Southern Urals Populations HEALTH PROTECTION AGENCY HPA participó en un FP7: This project aims to improve estimates of the risks of long-term health effects associated with protracted external and internal radiation e...
Financiado
ICEPURE: The impact of climatic and environmental factors on personal ultraviolet radiation exposure and huma... HEALTH PROTECTION AGENCY HPA participó en un FP7: We will determine the adverse and beneficial health effects of personal UVR exposure and their relationships with climatic and environmental...
Financiado
BIOVACSAFE: Biomarkers For Enhanced Vaccine Safety HEALTH PROTECTION AGENCY HPA participó en un FP7: BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised...
Financiado
HAMLET: Human ModeL MATROSHKA for Radiation Exposure Determination of Astronauts HEALTH PROTECTION AGENCY HPA participó en un FP7: The European Space Agency’s project MATROSHKA (MTR), dedicated to determine the radiation load on astronauts in- and outside the Internation...
Financiado
TROCAR: Translational Research on Combating Antimicrobial Resistance HEALTH PROTECTION AGENCY HPA participó en un FP7: The health care systems of most European countries are based on a continuum from acute care hospitals, though other health care facilities t...
Financiado
DEVANI: Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune re... HEALTH PROTECTION AGENCY HPA participó en un FP7: Direct vaccination cannot prevent diseases that affect neonates in the first days of life. Group B Streptococcus (GBS) is the major cause of...
Financiado
TENEB: Towards a European Network of Excellence in Biological Dosimetry HEALTH PROTECTION AGENCY HPA participó en un FP7: In recent years a number of accidents have occurred that show the necessity to be prepared for a possible large-scale radiological accident...
Financiado
PROCARDIO: Cardiovascular Risk from Exposure to Low dose and Low dose rate Ionizing Radiation HEALTH PROTECTION AGENCY HPA participó en un FP7: Epidemiological evidence has established a link between cardiovascular disease and exposure of the heart and major vessels to doses above 50...
Financiado
RENEB: Realizing the European Network in Biodosimetry HEALTH PROTECTION AGENCY HPA participó en un FP7: Creating a sustainable network in biological dosimetry that involves a large number of experienced laboratories throughout the EU will signi...
Financiado
ENETRAP-II: European Network for Education and Training in Radiation Protection II HEALTH PROTECTION AGENCY HPA participó en un FP7: As is the case with all nuclear expertise, there is a trend of a decreasing number of experts in radiation protection due to various reasons...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.